Quality and stability assessment can focus on the defined composition and relevant activity of the preparation rather than yeast viability alone.

Depending on its technical characteristics, a Saccharomyces Boulardii -derived preparation may be evaluated across different dosage forms.

It provides an opportunity to explore postbiotic concepts based on a well-studied probiotic yeast.

The ingredient can be considered for product-development strategies extending beyond conventional live probiotics.

Research into microbial-derived components and metabolites continues to investigate interactions between microorganisms and the gastrointestinal environment

Postbiotic preparations can be evaluated for inclusion in microbiome-focused nutritional products.

Potential dosage forms include capsules, tablets and powder formulations, depending on the characteristics of the preparation.

Selected preparations may be evaluated for use in food matrices where stability and compatibility have been established.

Certain preparations may be investigated for liquid formulations following appropriate formulation and stability testing.

Saccharomyces Boulardii  postbiotic may be evaluated alongside other postbiotics, probiotics, prebiotics or functional ingredients.

No. Saccharomyces boulardii is a yeast, making it biologically different from bacterial probiotics such as Lactobacillus and Bifidobacterium.

Live Saccharomyces Boulardii  preparations have been used as probiotics. A postbiotic preparation, however, is non-living and should be evaluated separately from the live probiotic form.

The probiotic form contains viable yeast, whereas the postbiotic form is a non-living preparation derived from the microorganism. Consequently, the quality and stability parameters are different.

A postbiotic preparation is non-living and does not depend on viable yeast. The exact microbiological specifications should be confirmed for the individual product.

CFU measures viable microorganisms. Since a postbiotic is non-living, CFU is generally not the defining specification.

Not necessarily. Heat inactivation may produce a non-living preparation, but heat treatment alone does not establish that the resulting material meets the applicable definition and characterization criteria for a postbiotic.

Yes, depending on the physical properties, dosage and stability characteristics of the specific preparation.

Potentially. Powder sachet applications can be evaluated based on moisture sensitivity, flow properties, stability and compatibility with other ingredients.

Potentially. Suitability depends on the specific preparation, food matrix, processing conditions, stability and applicable regulatory requirements.

Potentially. Multi-postbiotic formulations can be investigated, provided compatibility, stability and the intended formulation rationale are established.

Potentially. The interaction between the postbiotic preparation and live microorganisms should be evaluated during formulation development.

SwissMedicare Probiotics supports B2B ingredient requirements and can discuss bulk supply according to the specific preparation, quantity, technical specifications and destination market.

Yes. Custom formulation projects can be evaluated based on the desired dosage form, ingredient combination, processing conditions, stability objectives and target market.

Saccharomyces boulardii is commonly used to support gastrointestinal health, and it is extensively studied in digestive research, including antibiotic-associated and travellers' digestive upset. As a postbiotic, it is used in gut microbiome research, functional nutrition, dietary supplements, functional foods and beverages. SwissMedicare Probiotics supplies Saccharomyces boulardii postbiotic in bulk for these applications.

Saccharomyces boulardii is associated with gastrointestinal health support; research suggests live S. boulardii may help maintain digestive balance, particularly during antibiotic use. Benefits depend on the strain, preparation and dose. Saccharomyces boulardii postbiotic is a non-living preparation whose characteristics depend on strain, fermentation, inactivation and processing, so claims must be based on preparation-specific evidence.

Saccharomyces boulardii is thought to work by passing through the digestive tract, where research suggests it interacts with the gut lining, supports the intestinal barrier, modulates immune responses and helps maintain microbial balance. Being a yeast, it is unaffected by antibacterial antibiotics. Postbiotic forms deliver yeast-derived cellular components and metabolites rather than living cells.

There is no universal recommended dosage of Saccharomyces boulardii; dose depends on the strain, preparation, intended use and local regulations. For Saccharomyces boulardii postbiotic, CFU is generally not the defining parameter because the cells are non-living, so dosage is set during formulation development. Follow product labelling or a healthcare professional's advice.

Saccharomyces boulardii is generally well tolerated; mild side effects can include gas, bloating or constipation. Rare yeast bloodstream infections (fungemia) have been reported with live S. boulardii, mainly in critically ill or immunocompromised patients and those with central venous catheters. People in these groups, or who are pregnant, should consult a healthcare professional before use.

The main difference is that Saccharomyces boulardii is a probiotic yeast, while most probiotics are bacteria such as Lactobacillus and Bifidobacterium. Because it is a yeast, S. boulardii is not killed by antibacterial antibiotics. A Saccharomyces boulardii postbiotic differs further: it is non-living and does not depend on viable cells or CFU counts.

Saccharomyces boulardii is commonly taken daily in studies and supplements, and it is generally well tolerated for short to medium-term use. Whether daily long-term use suits you depends on your health status and the product, so consult a healthcare professional, especially if you are immunocompromised, critically ill, pregnant or have a central venous catheter.

Saccharomyces boulardii tablets are used mainly to support digestive and gastrointestinal health, often during antibiotic use or travel, and to help maintain gut microbial balance. Tablets are one of the formats suitable for Saccharomyces boulardii postbiotic, alongside capsules, powder sachets and functional foods. SwissMedicare Probiotics supplies the postbiotic ingredient in bulk for tablet manufacturers.